Hybio Pharmaceutical (300199) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.177x

Based on the latest financial reports, Hybio Pharmaceutical (300199) has a cash flow conversion efficiency ratio of 0.177x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.78 Million ≈ $17.23 Million USD) by net assets (CN¥666.08 Million ≈ $97.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hybio Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Hybio Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300199 liabilities breakdown for a breakdown of total debt and financial obligations.

Hybio Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hybio Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen Colibri Technologies Co Ltd SHE:002957	0.026x
Seadrill Limited NYSE:SDRL	-0.014x
Sinocelltech Group Ltd SHG:688520	0.137x
Scorpio Tankers Inc. F:S0QA	0.044x
An Hui Wenergy Co Ltd SHE:000543	0.133x
Worthington Industries Inc NYSE:WOR	0.053x
VGP NV BR:VGP	-0.006x
Harley-Davidson Inc NYSE:HOG	0.048x

Annual Cash Flow Conversion Efficiency for Hybio Pharmaceutical (2007–2024)

The table below shows the annual cash flow conversion efficiency of Hybio Pharmaceutical from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300199 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥597.05 Million ≈ $87.37 Million	CN¥164.71 Million ≈ $24.10 Million	0.276x	+6209.36%
2023-12-31	CN¥783.21 Million ≈ $114.61 Million	CN¥-3.54 Million ≈ $-517.51K	-0.005x	-137.05%
2022-12-31	CN¥1.30 Billion ≈ $189.78 Million	CN¥15.81 Million ≈ $2.31 Million	0.012x	-87.19%
2021-12-31	CN¥1.65 Billion ≈ $241.15 Million	CN¥156.83 Million ≈ $22.95 Million	0.095x	+232.72%
2020-12-31	CN¥1.68 Billion ≈ $245.53 Million	CN¥47.99 Million ≈ $7.02 Million	0.029x	-38.96%
2019-12-31	CN¥2.23 Billion ≈ $326.77 Million	CN¥104.64 Million ≈ $15.31 Million	0.047x	+238.15%
2018-12-31	CN¥3.39 Billion ≈ $496.31 Million	CN¥47.00 Million ≈ $6.88 Million	0.014x	-74.81%
2017-12-31	CN¥3.88 Billion ≈ $568.47 Million	CN¥213.74 Million ≈ $31.28 Million	0.055x	-33.09%
2016-12-31	CN¥3.60 Billion ≈ $527.46 Million	CN¥296.41 Million ≈ $43.37 Million	0.082x	+56.20%
2015-12-31	CN¥2.64 Billion ≈ $385.92 Million	CN¥138.84 Million ≈ $20.32 Million	0.053x	-55.53%
2014-12-31	CN¥1.30 Billion ≈ $189.67 Million	CN¥153.43 Million ≈ $22.45 Million	0.118x	-13.29%
2013-12-31	CN¥1.12 Billion ≈ $164.51 Million	CN¥153.48 Million ≈ $22.46 Million	0.137x	+59.09%
2012-12-31	CN¥1.02 Billion ≈ $148.68 Million	CN¥87.19 Million ≈ $12.76 Million	0.086x	+15.57%
2011-12-31	CN¥976.09 Million ≈ $142.83 Million	CN¥72.48 Million ≈ $10.61 Million	0.074x	-75.48%
2010-12-31	CN¥180.59 Million ≈ $26.43 Million	CN¥54.69 Million ≈ $8.00 Million	0.303x	+48.18%
2009-12-31	CN¥127.74 Million ≈ $18.69 Million	CN¥26.11 Million ≈ $3.82 Million	0.204x	-55.67%
2008-12-31	CN¥99.23 Million ≈ $14.52 Million	CN¥45.75 Million ≈ $6.69 Million	0.461x	-54.21%
2007-12-31	CN¥48.70 Million ≈ $7.13 Million	CN¥49.04 Million ≈ $7.18 Million	1.007x	--

About Hybio Pharmaceutical

SHE:300199 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.68 Billion

CN¥18.32 Billion CNY

Market Cap Rank

#5281 Global

#1049 in China

Share Price

CN¥20.74

Change (1 day)

-1.14%

52-Week Range

CN¥13.62 - CN¥29.95

All Time High

CN¥29.95